ERBB2 and neoplasm: Using the Circ-Seq workflow, we processed 128 tumor and 13 normal-adjacent TN samples, 503 tumor and 56 normal-adjacent ER+ samples, and 162 tumor and 20 normal-adjacent HER2+ samples.